One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has progressed rapidly, showing promising outcomes for the treatment of genetic disorders, yet there remains ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, today announced that Christopher Hepler, ...

Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

Mass General Brigham and Saudi healthcare leaders collaborate to redefine the future of healthcare through AI, gene therapy, ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

UMass Chan Medical School has laid off or furloughed 200 employees, as the campus grapples with cuts to NIH research and ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.